Areas of the skin supplied by sensory fibers of the spinal nerves
VZV lab diagnosis
FA stain
HDF
Shell vial culture
VZV treatment
Acyclovir
Famciclovir
VZV vaccine
VZIG
Zoster immune plasma
In 1958, Burkitt first described a malignant lymphomatous disease which affected children and occurred with peculiarly high frequency in central and west Africa
Burkitt's lymphoma
Neoplasm frequently involved the jaw and abdomen, had a characteristic "starry sky" appearance, showing diffuse, primitive, poorly differentiated, large immature cells of lymphoblastic type
Epstein Barr Virus (EBV)
Associated with Burkitt's lymphoma, nasopharyngeal carcinoma and infectious mononucleosis (IM)
EBV clinical syndromes
Infectious mononucleosis
Chronic fatigue syndrome
Progressive reticular disease
Oral hairy leukoplakia
Burkitt's lymphoma
Nasopharyngeal carcinoma
EBV lab diagnosis
Atypical lymphocytes
Heterophil antibody
Serology
EBV treatment
Supportive
Atypical lymphocytes
Lymphocytes that have been activated to respond to a viral infection or sometimes a bacterial or parasitic infection
Cytomegalovirus (CMV)
Common and usually mild viral illness, rarely causes symptoms in healthy people, but can cause complications in immunocompromised and pregnant women
CMV prevalence
0.5 TO 1.0 of all newborns, 50% adult population
CMV transmission
Close contact with infected secretions
Blood transfusions
Organ transplant
Transplacental
CMV lab diagnosis
Cytology
Histology
Cell culture
Antigen detection
Molecular probe
Serology
CMV treatment
Supportive
Decrease immune suppression
Foscarnet
Glanciclovir
HHV 6 and HHV 7
Transmitted via respiratory route, site of latency is CD4cells, cause roseola (exanthem subitem) and associated with immunocompromised patients
HHV 6 and HHV 7 treatment
Glanciclovir
FOSCARNET
HHV 6 and HHV 7 diagnosis
PCR
Cell culture lymphocyte lines
HHV 8
Mode of transmission not known, site of latency is kaposis tumor cells, causes kaposis sarcoma